NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/31/2026
Back to search
Official data from USPTO
FORTVITA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
03/31/2026
Trademark type
Combined
Nice classes
5
Filing date
09/30/2024
Registration date
03/31/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/31/2026
Last transaction
03/31/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
24
Owner location
SINGAPORE, SG
Examiner
LE, KHANH M
Law office
M70
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized word "FORTVITA" with a design element to the left featuring two overlapping abstract leaves forming a vertical stem.
Holders and representatives
Holders
FORTVITA BIOLOGICS (SINGAPORE) PTE.LTD.
Representatives
Alex Patel Patel IP, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
medicines for human purposes for the treatment and prevention of cancerautoimmune and inflammatory diseasesrheumatoid arthritiscardiovascular diseases and infectious diseases; pharmaceutical preparations for the treatment and prevention of cancerautoimmune and inflammatory diseasesrheumatoid arthritiscardiovascular diseases and infectious diseases; vaccines; drugs for medical purposes for the treatment and prevention of cancerautoimmune and inflammatory diseasesrheumatoid arthritiscardiovascular diseases and infectious diseases; biological preparations for medical use for the treatment and prevention of cancerautoimmune and inflammatory diseasesrheumatoid arthritiscardiovascular diseases and infectious diseases; diagnostic preparations for medical purposes; biological tissue cultures for medical purposes; chemical reagents for medical or veterinary purposes; pharmaceutical preparationsophthalmics; pharmaceutical preparations for the treatment of ophthalmic diseases and conditions; None of the aforementioned goods relating to nutritional or dietary supplements
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/31/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/10/2026
PUBO
PUBLISHED FOR OPPOSITION
02/10/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/04/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/14/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/12/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/12/2026
ALIE
ASSIGNED TO LIE
01/12/2026
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
12/26/2025
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
10/14/2025
GNSI
INQUIRY TO SUSPENSION E-MAILED
10/14/2025
CNSI
SUSPENSION INQUIRY WRITTEN
10/14/2025
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
10/09/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/08/2025
GNSL
LETTER OF SUSPENSION E-MAILED
04/08/2025
CNSL
SUSPENSION LETTER WRITTEN
04/08/2025
DOCK
ASSIGNED TO EXAMINER
04/07/2025
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/04/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/04/2025
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
10/11/2024
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
10/11/2024
NWAP
NEW APPLICATION ENTERED
09/30/2024
Continuous trademark protection
Get notified about every new filing that threatens FORTVITA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.